ASCENDIS PHARMA A/S - ADR (ASND) Institutional Ownership Changes & 13F Activity

ASCENDIS PHARMA A/S - ADR (ASND) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Renaissance Technologies LLC, Polen Capital Management, Sequoia Financial Advisors, and Lone Pine Capital.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCBuy34,633117,332$26,837,348
Q1 2026Polen Capital ManagementBuy6011,812$414,459
Q4 2025Polen Capital ManagementSell-1,5551,211$258,234
Q3 2025Polen Capital ManagementBuy472,766$549,908
Q2 2025Polen Capital ManagementBuy2,7192,719$469,299
Q4 2023Sequoia Financial AdvisorsBuy5,8115,811$731,896
Q2 2023Renaissance Technologies LLCBuy27,61782,699$7,381
Q1 2021Lone Pine CapitalBuy542,4481,436,981$185,198
Q4 2020Lone Pine CapitalBuy894,533894,533$149,190
Q2 2020Renaissance Technologies LLCBuy4,00455,082$8,147
Q1 2020Renaissance Technologies LLCBuy21,23551,078$5,752
Q4 2019Renaissance Technologies LLCSell-44,75629,843$4,152
Q3 2019Renaissance Technologies LLCSell-105,20074,599$7,185
Q2 2019Renaissance Technologies LLCBuy91,000179,799$20,704
Q1 2019Renaissance Technologies LLCBuy46,89988,799$10,452
Q3 2018Renaissance Technologies LLCBuy35,26041,900$2,969
Q1 2018Renaissance Technologies LLCSell-8,8606,640$434
Q4 2017Renaissance Technologies LLCSell-18,00015,500$621
Q3 2017Renaissance Technologies LLCBuy8,03033,500$1,214
Q2 2017Renaissance Technologies LLCBuy25,47025,470$707

Frequently asked questions about ASND activity

  • Which institutional owners are buying ASND?

    Institutional owners buying ASND include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ASND activity?

    "Buy" means an investor increased their reported position in ASND compared to the prior reporting period. This reflects growing exposure to ASCENDIS PHARMA A/S - ADR (ASND) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ASND increasing?

    Institutional interest in ASND can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related ASND insights